Amphista Therapeutics
PrivateLast Round
Series B
Extension
Dec 13, 2022
Total Funding Raised
$60.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Amphista Therapeutics operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Series B Extension round in December 2022.
Amphista Therapeutics is a biotechnology company that develops next-generation targeted protein degradation therapeutics for the treatment of cancer and other severe diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amphista Therapeutics Comparables
Compare Amphista Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Plexium | 89% | |
| Pin Therapeutics | 84% | |
| Dunad Therapeutics | 84% |
For institutional investors. Book with your work email.
Amphista Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Dec 13, 2022 | ||||
| Series B | Mar 17, 2021 | ||||
| Series A | Apr 7, 2020 | ||||
| Seed | Dec 20, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Amphista Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forbion Capital Partners | Series B |
| BioMotiv | Series B, Series A |
| SV Health Investors | Series B Extension |
| Forbion | Series B |
| Advent Life Sciences | Series B, Seed, Series B Extension, Series A |
| European Investment Fund | Seed, Series A |
| Gilde Healthcare | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 77% MoM.
- Jul 25, 2026
Monthly visitors increased 51% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventNov 5, 2026
Amphista Therapeutics is to present AMX-883 data in an oral presentation at the American Society of Hematology (ASH) Annual Meeting in Louisiana on Dec 12th–15th '26.
For institutional investors. Book with your work email.
Amphista Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Amphista Therapeutics's valuation, stock price, and market status.
Is Amphista Therapeutics a public or private company?
Amphista Therapeutics is a private company.
What is the current stock price of Amphista Therapeutics?
Amphista Therapeutics is a private company, so its shares have no public market price. Caplight tracks Amphista Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Amphista Therapeutics worth (valuation)?
Valuation information for Amphista Therapeutics is not publicly available.
Can I buy Amphista Therapeutics stock?
Amphista Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Amphista Therapeutics's last funding round?
Amphista Therapeutics's most recent funding round was Series B Extension on December 13, 2022.
Who are the main investors in Amphista Therapeutics?
Key investors in Amphista Therapeutics include Forbion Capital Partners, SV Health Investors, Forbion, Advent Life Sciences, Gilde Healthcare.
Will Amphista Therapeutics IPO soon?
No public IPO plans have been announced for Amphista Therapeutics.
How can I track Amphista Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Amphista Therapeutics's shares on secondary markets.